Antonio Costanzo

46PUBLICATIONS
208CO-AUTHORS
Molecular targetsAllergyEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Oct 01, 2026
Long-Term Disease Control During Continuous Treatment with Upadacitinib and Baricitinib for Moderate-to-Severe Atopic Dermatitis: a Real-World Monocentric Retrospective Study.

|Jul 25, 2026
JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study.

|Jul 09, 2026
ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype.

|Jul 03, 2026
Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.

|May 26, 2026
The Importance of Achieving High Treatment Targets in Atopic Dermatitis: A Narrative Review.

|Apr 24, 2026
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study.

Pageof 8

Frequent Collaborators

23 joint publications

Luigi Gargiulo

18 joint publications

Luciano Ibba

13 joint publications

Mario Valenti

10 joint publications

Alessandra Narcisi